How should ADHD be treated?

Psychologist

Volumn 13, Issue 12, 2000, Pages 598-602

  Baldwin, Steve ^a   Cooper, Paul ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

EID: 0034355845     PISSN: 09528229     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (21)

1. Anderson, R., & Baldwin, S. (2000)-What's in a name? Amphetamine and methylphenidate. Journal of Substance Use, 5, 89-91.
2. Angell, M. (2000). Is academic medicine for sale? New England Journal of Medicine, 342, 1516-1518.
3. Baldwin, S. (in press). Impact evaluation of a mass media education campaign on clinic service provision for minors diagnosed with ADHD/ADD: Audit survey of 80 index families, International Journal of Risk and Safety in Medicine.
4. Baldwin, S., & Anderson, R. (2000),The cult of methylphenidate: Clinical update. Critical Public Health, 10, 81-86.
5. Breggin, P. (1999), Psychostimulants in the treatment of children diagnosed with ADHD: Part I - Acute risks and psychological effects. Ethical Human Sciences and Services, 1, 13-33.
6. Breggin, P. (2000).The NIMH multimodal study of treatment for attention-deficit/hyperactivity disorder: A critical analysis. International Journal of Risk and Safety in Medicine, 13, 15-22.
7. British Psychological Society (2000). Attention deficit/hyperactivity disorder (AD/HD): Guidelines and principles for successful multi-agency working, Leicester: Author.
8. BW Health Wire (1999). IMS health data show expanding pharmaceutical market growth - Three-way tie for number one in global pharmaceutical sales. Biomedicine and Pharmacotherapy, 53, 290-292.
9. Detweller, R., Hicks, A., & Hicks, M. (1999). A multimodal approach to the assessment and management of AD/HD. In P. Cooper & K. Bilton (Eds.). ADHD: Research, practice and opinion (pp. 43-59). London: Whurr.
10. Greenhill, L. (1998). Childhood ADHD: Pharmacological treatments. In P. Nathan & J. Gorman (Eds.), A guide to treatments that work (pp. 42-64). Oxford: Oxford University Press.
11. Hinshaw, S., Klein, R., & Abikoff, H. (1998). Childhood ADHD: nonpharmacological and combination treatments,' in P. Nathan & J. Gorman (Eds.), A Guide to treatments that work (pp. 26-41). Oxford: Oxford University Press.
12. Kinder, J. (1999). ADHD, a different viewpoint Holistic and other approaches. In P. Cooper & K. Bilton (Eds.), ADHD: Research, practice and opinion (pp. 138-157). London: Whurr.
13. MTA Cooperative Group (1999a). A 14-month randomized clinical trial of treatment strategies for attention-deficit/hyperactivity disorder. Archives of General Psychiatry, 56, 1073-1086.
14. MTA Cooperative, Group (1999b). Moderators and mediators of treatment response for children with attentlon-deficit/hyperactivity disorder. Archives of General Psychiatry, 56, 1086-1096.
15. National Institutes of Health (1998). Consensus statement: Diagnosis and treatment of attention deficit hyperactivity disorders. Rockville, MD: National Institute of Mental Health.
16. Robin, A. L. & Barkley, R. A. (1998). ADHD in adolescents: Diagnoses and treatment New York: Guilford.
17. Ruesch H. (1992). Naked empress or the great medical fraud. Massagno/Lugano: CIVIS Publications.
18. Stahl, S. (2000). Essential psychopharmacology: Neuroscientific basis and practical applications (2nd ed.). Cambridge: Cambridege University Press.
19. Tannock, R. (1998). ADHD: advances in cognitive, neurobiological and genetic research. Journal of Child Psychology and Psychiatry, 39, 69-95.
20. Teeter, P. (1998). Interventions for ADHD: Treatment in developmental context, New York: Guilford.
21. Waters & Kraus (2000). Ritalin fraud [Online]. http://www.ritalinfraud.com.